Since its discovery in 1984 by Svetlana Mosjov, GLP-1 and its analogs (such as semaglutide, liraglutide, and dulaglutide) have rapidly become cornerstone treatments for type 2 diabetes mellitus (T2DM) and obesity
Healthcare providers must tell patients about these risks and benefits
Zhu G, Fang Q, Zhu F, Huang D, Chen Y
I was able to really refocus my diet that way
It won't have the same degree of weight loss from what we can see in the early trials, she advises, but it will help retain lean muscle mass, which we inevitably lose over our lifetime. Given that semaglutide is a lifelong drug, the long-term data on GLP-1 agonists is reassuringly positive